Global Community

TheGapReport: NVIDIA Corporation (NVDA) Q2 2027 (may 20 - aug 26) NVIDIA's Q2 fiscal 2027 results, arrived with a structural admission that management had not offered 90 days earlier: supply is now the binding constraint on the company's growth, not demand, not product readiness, not market development. The $96 billion quarter — record revenue, fourth consecutive year-over-year acceleration — lands differently when the accompanying FY2028 guide of approximately 70% growth is immediately qualified as supply-constrained, with unconstrained demand running "a lot higher." ✅ Delivered Vera Rubin Launch — Production and Ramp In May, Colette Kress said Vera Rubin production shipments would commence in the second half of fiscal 2027, starting in Q3.Read more

Veeva runs behind-the-scenes software that drugmakers rely on for tightly controlled work, where a mistake can slow a study or paperwork needed to bring medicines to patients. With new AI tools being built right into those existing systems, the big question is whether Veeva can turn that built-in trust into a new wave of growth—without investors overpaying.Read more

Magma’s hotel business is holding up, giving the company a steadier base while it tries to cut costs and narrow its losses. Big share-related funding moves also reshape its finances, but the next few quarters hinge on whether better hotel demand and tighter spending can turn stability into a real recovery.Read more

Kee Ming Group Berhad began the financial year ending 31 March 2027 on an encouraging note, supported by stronger project activity, higher quarterly revenue and continued growth in its outstanding order book. For the first quarter ended 30 June 2026, the mechanical and electrical (M&E) engineering specialist recorded revenue of RM48.40 million.Read more

Polaris pushes to grow its slice of Japan’s hotel market even as fewer visitors arrive from China, betting that bigger scale and a broader mix of hotel styles keep profits rising. It also leans more on lower-risk operating agreements and adds new customer perks, but the near-term outlook still looks a bit cloudy.Read more

Key Points: Sparc AI (CSE:SPAI) is tackling a growing global problem: drones and aircraft failing when GPS is jammed or spoofed, a problem already driving massive government losses globally. Its Overwatch platform is a software solution to the hardware problem, using AI and existing sensors making it highly scalable across fleets.Read more

Restar’s core device business is seeing demand pick up in industrial and auto markets, but tougher competition is weighing on another part of the company. With the current business plan nearing its final year, the next moves on acquisitions and new business units could decide whether momentum holds or fades.Read more

Reservoir Link’s latest results look ugly at first glance, but a big one-off write-down hides a business that’s lining up new work and fresh growth paths. With longer-term contracts, a push into nearby countries, and early steps into cleaner-energy and gas-related projects, the next year could look very different—if execution holds.Read more

Medpace helps smaller drug makers run clinical trials, and its edge comes from doing the whole job end-to-end with deep disease expertise and a global setup that’s hard to copy. But customers can walk away from projects quickly if funding dries up or a trial goes wrong, and the stock already assumes a lot goes right from here.Read more